Skip to main content

A phase II, open-label, multicenter study of GW572016 in patients with trastuzumab-refractory metastatic breast cancer.

Publication ,  Conference
Blackwell, KL; Kaplan, EH; Franco, SX; Marcom, PK; Maleski, JE; Sorensen, MJ; Berger, MS
Published in: JOURNAL OF CLINICAL ONCOLOGY
July 15, 2004

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

ISSN

0732-183X

Publication Date

July 15, 2004

Volume

22

Issue

14

Start / End Page

196S / 196S

Location

New Orleans, LA

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

40th Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Blackwell, K. L., Kaplan, E. H., Franco, S. X., Marcom, P. K., Maleski, J. E., Sorensen, M. J., & Berger, M. S. (2004). A phase II, open-label, multicenter study of GW572016 in patients with trastuzumab-refractory metastatic breast cancer. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 22, pp. 196S-196S). New Orleans, LA: AMER SOC CLINICAL ONCOLOGY.
Blackwell, K. L., E. H. Kaplan, S. X. Franco, P. K. Marcom, J. E. Maleski, M. J. Sorensen, and M. S. Berger. “A phase II, open-label, multicenter study of GW572016 in patients with trastuzumab-refractory metastatic breast cancer.” In JOURNAL OF CLINICAL ONCOLOGY, 22:196S-196S. AMER SOC CLINICAL ONCOLOGY, 2004.
Blackwell KL, Kaplan EH, Franco SX, Marcom PK, Maleski JE, Sorensen MJ, et al. A phase II, open-label, multicenter study of GW572016 in patients with trastuzumab-refractory metastatic breast cancer. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2004. p. 196S-196S.
Blackwell, K. L., et al. “A phase II, open-label, multicenter study of GW572016 in patients with trastuzumab-refractory metastatic breast cancer.JOURNAL OF CLINICAL ONCOLOGY, vol. 22, no. 14, AMER SOC CLINICAL ONCOLOGY, 2004, pp. 196S-196S.
Blackwell KL, Kaplan EH, Franco SX, Marcom PK, Maleski JE, Sorensen MJ, Berger MS. A phase II, open-label, multicenter study of GW572016 in patients with trastuzumab-refractory metastatic breast cancer. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2004. p. 196S-196S.

Published In

JOURNAL OF CLINICAL ONCOLOGY

ISSN

0732-183X

Publication Date

July 15, 2004

Volume

22

Issue

14

Start / End Page

196S / 196S

Location

New Orleans, LA

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

40th Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences